clinicaltrials.gov epithalon Interview with Director Deborah Zarin Bioregulator Peptides for Aging (2026):

Thus, passive diffusion of peptides is very limited unless the peptides possess an amphipathic structure or use synthetic means to modify the lipophilicity [2,6], such as the glycosylation strategy of peptides [12]

The downside is that it costs more, and there are potential side effects

Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users

As interest grows, compounds like BPC-157 and TB-500 are becoming central to modern recovery and performance protocols

It is a fundamental limitation of preclinical research

These cells are small enough to penetrate the BBB and are capable of repairing and restoring brain tissue effectively